Tectonic Therapeutic (TECX) News Today $15.62 -1.05 (-6.30%) Closing price 04:00 PM EasternExtended Trading$15.91 +0.29 (+1.86%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75March 28, 2025 | americanbankingnews.comTectonic Therapeutic files to sell 3.69M shares of common stock for holdersMarch 27, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buMarch 25, 2025 | marketbeat.comWells Fargo & Company Has Lowered Expectations for Tectonic Therapeutic (NASDAQ:TECX) Stock PriceWells Fargo & Company cut their price objective on Tectonic Therapeutic from $112.00 to $101.00 and set an "overweight" rating for the company in a report on Friday.March 22, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Releases Quarterly Earnings Results, Beats Expectations By $0.08 EPSTectonic Therapeutic (NASDAQ:TECX - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.84) EPS for the quarter, topping analysts' consensus estimates of ($0.92) by $0.08.March 21, 2025 | marketbeat.comTectonic Therapeutic Inc (TECX) Reports Q4 2024 Net Loss of $12. ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 20, 2025 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Stake Trimmed by Atlas Venture Life Science Advisors LLCAtlas Venture Life Science Advisors LLC cut its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 79.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,447 shares of the company'March 7, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Decrease in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 888,500 shares, a decrease of 16.2% from the January 31st total of 1,060,000 shares. Based on an average trading volume of 284,700 shares, the short-interest ratio is currently 3.1 days. Currently, 10.3% of the shares of the company are sold short.March 6, 2025 | marketbeat.comTectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on ThursdayTectonic Therapeutic (NASDAQ:TECX) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Rating of "Buy" by BrokeragesTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has been given an average rating of "Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendaFebruary 28, 2025 | marketbeat.comTectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying RecentlyFebruary 22, 2025 | msn.comTectonic Therapeutic to Participate in March Investor ConferencesFebruary 20, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,060,000 shares, an increase of 60.3% from the January 15th total of 661,100 shares. Based on an average daily volume of 260,900 shares, the short-interest ratio is currently 4.1 days. Currently, 13.8% of the shares of the company are short sold.February 13, 2025 | marketbeat.comDeep Track Capital, LP Acquires Significant Stake in Tectonic Therapeutic IncFebruary 10, 2025 | gurufocus.comTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Insider Buying ActivityTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Insider Buying ActivityFebruary 10, 2025 | marketbeat.comTectonic Therapeutic director Timothy Springer buys $39.9 million in stockFebruary 8, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) CFO Daniel Lochner Purchases 4,617 SharesFebruary 8, 2025 | insidertrades.comInsider Buying: Daniel Lochner Acquires Shares of Tectonic Therapeutic Inc (TECX)February 7, 2025 | gurufocus.comDaniel Lochner Buys 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) CFO Daniel Lochner bought 4,617 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The stock was purchased at an average price of $54.14 per share, with a total value of $249,964.38. Following the transaction, the chief financial officer now directly owns 4,617 shares in the company, valued at $249,964.38. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.February 7, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Director Buys $6,999,977.16 in StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) Director Timothy A. Springer bought 129,294 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The shares were purchased at an average cost of $54.14 per share, for a total transaction of $6,999,977.16. Following the acquisition, the director now owns 4,226,058 shares of the company's stock, valued at $228,798,780.12. This represents a 3.16 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.February 7, 2025 | marketbeat.comTectonic: Expansion Of TX45 Candidate Possible After Positive Interim DataFebruary 5, 2025 | seekingalpha.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 3.2% - Time to Sell?Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 3.2% - Here's What HappenedFebruary 4, 2025 | marketbeat.comTectonic secures $185 million in private equity fundingFebruary 3, 2025 | msn.comTectonic announces ~$185M capital raiseFebruary 3, 2025 | msn.comTectonic Therapeutic announces $185M private placementFebruary 3, 2025 | markets.businessinsider.comTectonic Therapeutic, Inc. Announces $185 Million Private Investment in Public Equity FinancingFebruary 3, 2025 | quiverquant.comTectonic Announces $185 Million Private PlacementFebruary 3, 2025 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from AnalystsShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned a consensus rating of "Buy" from the six analysts that are presently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the companyFebruary 3, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Trading Up 6.7% Following Analyst UpgradeJanuary 31, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00Wells Fargo & Company upped their price objective on Tectonic Therapeutic from $79.00 to $112.00 and gave the company an "overweight" rating in a research note on Friday.January 31, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Stock, Short Interest ReportJanuary 30, 2025 | benzinga.comTectonic Therapeutic Shares Hit 52-Week High After Positive Trial DataJanuary 30, 2025 | marketwatch.comPiper Sandler Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)January 30, 2025 | markets.businessinsider.comTectonic jumps on positive data from early-stage trial for lead assetJanuary 30, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) Reaches New 1-Year High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Still a Buy?January 30, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3% - Here's What HappenedTectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3% - Time to Sell?January 30, 2025 | marketbeat.comTectonic Therapeutic stock soars on positive trial dataJanuary 30, 2025 | investing.comTectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45January 30, 2025 | markets.businessinsider.comTectonic Therapeutic Reports Positive Interim Data on TX45 for Treatment of Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection FractionJanuary 30, 2025 | quiverquant.comTectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEFJanuary 30, 2025 | globenewswire.comLeerink says Eli Lilly news causes concern about Tectonic’s TX45 successJanuary 29, 2025 | markets.businessinsider.comTectonic shares tumble after rival drug trial terminationJanuary 29, 2025 | msn.comEli Lilly trial update on kidney drug hurts TectonicJanuary 29, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 13.3% - Here's What HappenedTectonic Therapeutic (NASDAQ:TECX) Shares Down 13.3% - Here's What HappenedJanuary 28, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Up 8.2% - Here's What HappenedTectonic Therapeutic (NASDAQ:TECX) Shares Up 8.2% - Should You Buy?January 24, 2025 | marketbeat.comTectonic Therapeutic participates in a conference call with Piper SandlerJanuary 23, 2025 | markets.businessinsider.comClarius Group LLC Buys New Position in Tectonic Therapeutic (NASDAQ:TECX)Clarius Group LLC purchased a new position in Tectonic Therapeutic (NASDAQ:TECX - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 10,130 shares of the company's stock, valued at approximately $468,000. ClariuJanuary 20, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 8.8% - Should You Sell?Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 8.8% - Time to Sell?January 10, 2025 | marketbeat.com Remove Ads Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address TECX Media Mentions By Week TECX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECX News Sentiment▼0.540.61▲Average Medical News Sentiment TECX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECX Articles This Week▼03▲TECX Articles Average Week Remove Ads Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARS Pharmaceuticals News Today Ardelyx News Today Evotec News Today Ocular Therapeutix News Today Structure Therapeutics News Today Calliditas Therapeutics AB (publ) News Today Iovance Biotherapeutics News Today Syndax Pharmaceuticals News Today Aurinia Pharmaceuticals News Today Spyre Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECX Stock Free TECX Stock Alerts